Emily Berry

451 total citations
16 papers, 253 citations indexed

About

Emily Berry is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emily Berry has authored 16 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emily Berry's work include Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Uterine Myomas and Treatments (3 papers). Emily Berry is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Uterine Myomas and Treatments (3 papers). Emily Berry collaborates with scholars based in United States, Philippines and Honduras. Emily Berry's co-authors include John R. Lurain, Jon Clardy, Jennifer Hardt, Julie Kim, Anna V. Hoekstra, Elizabeth C. Sefton, Erica E. Marsh, Ping Yin, Serdar E. Bulun and Zhenxiao Lu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Emily Berry

15 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Berry United States 8 107 106 71 36 36 16 253
Satoshi Yanagida Japan 9 127 1.2× 103 1.0× 63 0.9× 29 0.8× 29 0.8× 15 210
Baoxia Gu China 4 88 0.8× 106 1.0× 64 0.9× 40 1.1× 60 1.7× 6 238
Zimin Pan China 9 78 0.7× 67 0.6× 59 0.8× 62 1.7× 48 1.3× 25 235
Jack Basil United States 7 96 0.9× 77 0.7× 46 0.6× 53 1.5× 66 1.8× 17 257
Peng-Hui Wang Taiwan 10 137 1.3× 81 0.8× 83 1.2× 20 0.6× 11 0.3× 17 269
R.I. Olivier Netherlands 5 249 2.3× 55 0.5× 51 0.7× 54 1.5× 70 1.9× 6 342
Heinrich Salzer Austria 8 204 1.9× 91 0.9× 61 0.9× 58 1.6× 25 0.7× 14 315
Barnaby Rufford United Kingdom 6 171 1.6× 103 1.0× 35 0.5× 41 1.1× 29 0.8× 12 244
Sili He China 10 59 0.6× 80 0.8× 141 2.0× 25 0.7× 111 3.1× 18 309
G. Emons Germany 9 197 1.8× 137 1.3× 89 1.3× 58 1.6× 14 0.4× 19 357

Countries citing papers authored by Emily Berry

Since Specialization
Citations

This map shows the geographic impact of Emily Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Berry more than expected).

Fields of papers citing papers by Emily Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Berry. The network helps show where Emily Berry may publish in the future.

Co-authorship network of co-authors of Emily Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Berry. A scholar is included among the top collaborators of Emily Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Berry. Emily Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Berry, Emily, Maria A. Fragala-Pinkham, Susan Riley, et al.. (2023). Baseline Range of Motion, Strength, Motor Function, and Participation in Youth with Hutchinson-Gilford Progeria Syndrome. Physical & Occupational Therapy In Pediatrics. 43(4). 482–501.
2.
Swetzig, Wendy M., Valery Adorno-Cruz, Mario Javier Pineda, et al.. (2021). Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial. Gynecologic Oncology. 163(1). 57–63. 5 indexed citations
4.
Swetzig, Wendy M., John R. Lurain, Emily Berry, et al.. (2019). Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.. Journal of Clinical Oncology. 37(15_suppl). 5538–5538. 3 indexed citations
5.
Winder, Abigail, Kruti P. Maniar, Anna V. Hoekstra, et al.. (2018). Surgery and Platinum/Etoposide-Based Chemotherapy for the Treatment of Epithelioid Trophoblastic Tumor. International Journal of Gynecological Cancer. 28(6). 1117–1122. 12 indexed citations
6.
Gross, Jeffrey P., Jonathan Strauss, John R. Lurain, et al.. (2016). Impact of obesity on treatment-related adverse events, disease recurrence, and survival in women with cervical carcinoma. Journal of Radiation Oncology. 5(2). 197–203. 4 indexed citations
7.
Carneiro, Benedito A., Julia A. Elvin, Suneel D. Kamath, et al.. (2015). FGFR3–TACC3: A novel gene fusion in cervical cancer. SHILAP Revista de lepidopterología. 13. 53–56. 52 indexed citations
8.
Chuang, Linus, et al.. (2015). Volunteering in Honduras: Results and Reflections. Journal of Clinical Oncology. 33(18). 2001–2003. 2 indexed citations
9.
Helenowski, Irene, et al.. (2015). A Comparison of Survival and Recurrence Outcomes in Patients With Endometrial Cancer Undergoing Robotic Versus Open Surgery. Journal of Minimally Invasive Gynecology. 22(6). 961–967. 23 indexed citations
10.
Berry, Emily, Kellie S. Matthews, Diljeet K. Singh, et al.. (2009). An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer. Gynecologic Oncology. 113(1). 63–67. 16 indexed citations
11.
Hoekstra, Anna V., Elizabeth C. Sefton, Emily Berry, et al.. (2009). Progestins Activate the AKT Pathway in Leiomyoma Cells and Promote Survival. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1768–1774. 80 indexed citations
12.
Hoekstra, Anna V., Elizabeth C. Sefton, Emily Berry, et al.. (2009). Progestins Activate the AKT Pathway in Leiomyoma Cells and Promote Survival. Molecular Endocrinology. 23(4). 585–585. 1 indexed citations
13.
Berry, Emily, Steven R. Lindheim, Joseph P. Connor, et al.. (2008). Sonohysterography and Endometrial Cancer: Incidence and Functional Viability of Disseminated Malignant Cells. Obstetrical & Gynecological Survey. 63(12). 774–775. 1 indexed citations
14.
Berry, Emily, Steven R. Lindheim, Joseph P. Connor, et al.. (2008). Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells. American Journal of Obstetrics and Gynecology. 199(3). 240.e1–240.e8. 7 indexed citations
15.
Berry, Emily, Jennifer Hardt, Jon Clardy, John R. Lurain, & Julie Kim. (2008). Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1. Gynecologic Oncology. 112(2). 331–336. 21 indexed citations
16.
Berry, Emily, et al.. (2008). Vaginal metastases in gestational trophoblastic neoplasia.. PubMed. 53(7). 487–92. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026